ACTN4 and breast carcinoma: In particular, ellagic acid (MOL005858) has been shown to restrain pulmonary metastasis mainly via targeting ACTN4 and subsequently destroying β-catenin stabilization in breast cancer stem cells (Wang et al., 2017).